Stocks and Investing Stocks and Investing
Wed, March 31, 2021
[ 12:00 AM ] - WOPRAI
Martijn Rats Downgraded (BP) to Sell on, Mar 31st, 2021
[ 12:00 AM ] - WOPRAI
Brad Canino Initiated (AFMD) at Buy and Held Target at $150 on, Mar 31st, 2021
[ 12:00 AM ] - WOPRAI
Jared Garber Maintained (WING) at Strong Buy with Decreased Target to $145 on, Mar 31st, 2021
[ 12:00 AM ] - WOPRAI
Brad Canino Initiated (ZYME) at Buy and Held Target at $55 on, Mar 31st, 2021
[ 12:00 AM ] - WOPRAI
Stephen Bersey Initiated (ZM) at Strong Sell and Held Target at $250 on, Mar 31st, 2021
[ 12:00 AM ] - WOPRAI
Matthew Luchini Initiated (ARVN) at Buy and Held Target at $101 on, Mar 31st, 2021
[ 12:00 AM ] - WOPRAI
Brad Heffern Initiated (AVB) at Hold and Held Target at $193 on, Mar 31st, 2021
[ 12:00 AM ] - WOPRAI
Michael Walkley Upgraded (BB) to Hold and Decreased Target to $9 on, Mar 31st, 2021
[ 12:00 AM ] - WOPRAI
Andrew Kuske Downgraded (BAM) to Hold and Increased Target to $54 on, Mar 31st, 2021
[ 12:00 AM ] - WOPRAI
Simeon Gutman Maintained (AZO) at Buy on, Mar 31st, 2021
[ 12:00 AM ] - WOPRAI
Steve Valiquette Maintained (WBA) at Hold and Held Target at $55 on, Mar 31st, 2021
[ 12:00 AM ] - WOPRAI
Robert Bek Upgraded (TU) to Buy on, Mar 31st, 2021
[ 12:00 AM ] - WOPRAI
Nicholas Watts Initiated (TW) at Strong Buy on, Mar 31st, 2021
[ 12:00 AM ] - WOPRAI
David Strauss Upgraded (TXT) to Buy and Increased Target to $68 on, Mar 31st, 2021
[ 12:00 AM ] - WOPRAI
Robert Drbul Maintained (TGT) at Strong Buy with Increased Target to $225 on, Mar 31st, 2021
[ 12:00 AM ] - WOPRAI
Connor Lynagh Initiated (XYL) at Buy and Held Target at $120 on, Mar 31st, 2021
[ 12:00 AM ] - WOPRAI
Brad Heffern Initiated (UDR) at Hold and Held Target at $45 on, Mar 31st, 2021
[ 12:00 AM ] - WOPRAI
Jason Mills Maintained (ANGO) at Hold with Increased Target to $24 on, Mar 31st, 2021
[ 12:00 AM ] - WOPRAI
Deepak Mathivanan Initiated (AMZN) at Buy on, Mar 31st, 2021
Tue, March 30, 2021
[ 12:00 AM ] - WOPRAI
Neal Dingmann Downgraded (APA) to Hold and Decreased Target to $20 on, Mar 30th, 2021
[ 12:00 AM ] - WOPRAI
Mani Foroohar Reiterated (WVE) at Hold with Decreased Target to $7 on, Mar 30th, 2021
[ 12:00 AM ] - WOPRAI
Jason Bazinet Upgraded (YELP) to Strong Buy and Increased Target to $48 on, Mar 30th, 2021
[ 12:00 AM ] - WOPRAI
Jonathan Matuszewski Initiated (TPX) at Hold and Held Target at $38 on, Mar 30th, 2021
[ 12:00 AM ] - WOPRAI
Mark Astrachan Maintained (TGT) at Strong Buy with Increased Target to $230 on, Mar 30th, 2021
[ 12:00 AM ] - WOPRAI
John Vinh Upgraded (TXN) to Buy and Held Target at $225 on, Mar 30th, 2021
[ 12:00 AM ] - WOPRAI
Sheila Kahyaoglu Maintained (UAL) at Hold with Increased Target to $60 on, Mar 30th, 2021
[ 12:00 AM ] - WOPRAI
Ricky Goldwasser Maintained (WBA) at Hold with Increased Target to $52 on, Mar 30th, 2021
[ 12:00 AM ] - WOPRAI
Joshua Dennerlein Upgraded (WELL) to Strong Buy and Increased Target to $78 on, Mar 30th, 2021
[ 12:00 AM ] - WOPRAI
Jennifer Kim Initiated (AYTU) at Buy and Held Target at $220 on, Mar 30th, 2021
[ 12:00 AM ] - WOPRAI
Leland Gershell Downgraded (ASND) to Hold on, Mar 30th, 2021

Leland Gershell Downgraded (ASND) to Hold on, Mar 30th, 2021


Published on 2024-10-27 16:04:37 - WOPRAI, Leland Gershell
  Print publication without navigation


Leland Gershell of Oppenheimer, Downgraded "Ascendis Pharma A/S" (ASND) to Hold on, Mar 30th, 2021.

Leland has made no other calls on ASND in the last 4 months.



There are 2 other peers that have a rating on ASND. Out of the 2 peers that are also analyzing ASND, 0 agree with Leland's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Leland

  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $190 on, Friday, March 12th, 2021
  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $176 on, Thursday, March 11th, 2021
Contributing Sources